Quarterly report · Q1
3583.TEDINET S100OWKG
Period2022-04-01 → 2022-06-30
Filed2022-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.3bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥5.5bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.3bn | 2021-04-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | ¥154m | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥148m | 2021-04-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥178m | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥727m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥150m | 2021-04-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥231m | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥150m | 2021-04-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥161m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥537m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥104m | 2021-04-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥161m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥104m | 2021-04-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥9.5bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥9.4bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥8.8bn | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥4.0bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥4.0bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥5.5bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥5.4bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥4.9bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.6bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.5bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥58.32 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥194.04 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥37.48 | 2021-04-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 57.9% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.4% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.4% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 37
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-06-30 | ¥6m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-06-30 | ¥221,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥6m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-06-30 | −¥3m |
| jpcrp040300-q1r_E00584-000Medical Productsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥353m |
| jpcrp040300-q1r_E00584-000Medical Productsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥352m |
| jpcrp040300-q1r_E00584-000Medical Productsreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥1m |
| jpcrp040300-q1r_E00584-000Medical Productsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥25m |
| jpcrp040300-q1r_E00584-000Technological Productsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥981m |
| jpcrp040300-q1r_E00584-000Technological Productsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥981m |
| jpcrp040300-q1r_E00584-000Technological Productsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥205m |
| —segment total | revenue | 2022-04-01 → 2022-06-30 | ¥1.3bn |
| —segment total | revenue external | 2022-04-01 → 2022-06-30 | ¥1.3bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥1m |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥230m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-06-30 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-06-30 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥7m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-06-30 | ¥227m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-06-30 | ¥822,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-06-30 | ¥822,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-06-30 | −¥5m |
| jpcrp040300-q1r_E00584-000Medical Productsreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥329m |
| jpcrp040300-q1r_E00584-000Medical Productsreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥328m |
| jpcrp040300-q1r_E00584-000Medical Productsreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥891,000 |
| jpcrp040300-q1r_E00584-000Medical Productsreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥36m |
| jpcrp040300-q1r_E00584-000Technological Productsreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥973m |
| jpcrp040300-q1r_E00584-000Technological Productsreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥973m |
| jpcrp040300-q1r_E00584-000Technological Productsreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥190m |
| —segment total | revenue | 2021-04-01 → 2021-06-30 | ¥1.3bn |
| —segment total | revenue external | 2021-04-01 → 2021-06-30 | ¥1.3bn |
| —segment total | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥891,000 |
| —segment total | segment profit | 2021-04-01 → 2021-06-30 | ¥226m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-06-30 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-06-30 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥891,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-06-30 | ¥220m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 373
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)監査法人グラヴィタス | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)藤 本 良 治 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)飯 田 一 紀 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 1301975000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 1333010000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 5486187000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 149722000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 177622000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 727250000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 103578000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 161456000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 536508000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 106726000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 186382000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 619441000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 4901315000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 5528036000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 5416476000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 8845043000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 9543813000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 9441206000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 37.48 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 58.32 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 194.04 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.554 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.579 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.574 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 3092623 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 3092623 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 3092623 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 3092623 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 12600 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 3061700 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 30617 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 18323 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 3092623 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 30617 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 12600 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 12600 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0041 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |